Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 177,722 shares at $12.27 ($2.2M) on 2018-03-21, disclosed to the SEC on 2018-03-23.
Open-market sale of $2.2M CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.27 | 100,000 | $1.2M | 56.7% |
| 2 | $12.07 | 33,630 | $406K | 18.8% |
| 3 | $12.07 | 33,630 | $406K | 18.8% |
| 4 | $12.02 | 5,231 | $63K | 2.9% |
| 5 | $12.02 | 5,231 | $63K | 2.9% |
| Total | $12.18 avg | 177,722 |
| $2.2M |
| 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |